Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Medeiros-Ribeiro

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Journal of Physical Activity & Health|March 4, 2023
Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic DiseasesBruno Gualano, Sofia M Sieczkowska, Ítalo Ribeiro Lemes, et al.
Clinics (Sao Paulo, Brazil)|December 18, 2022
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster doseRosa M R Pereira, Marilia A Dagostin, Valeria F Caparbo, et al.
Arthritis Care & Research|November 22, 2021
Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus ErythematosusEmily F N Yuki, Eduardo F Borba, Sandra G Pasoto, et al.
Journal of Physical Activity & Health|June 8, 2023
No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After VaccinationFabiana Infante Smaira, Bruna Caruso Mazzolani, Ítalo Ribeiro Lemes, et al.
The Lancet. HIV|March 26, 2022
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort studyLucas C Netto, Karim Y Ibrahim, Camila M Picone, et al.
Revista Brasileira De Reumatologia|June 9, 2016
Guidelines for the management and treatment of periodic fever syndromes: Cryopyrin-associated periodic syndromes (cryopyrinopathies - CAPS)Maria Teresa R A Terreri, Wanderley Marques Bernardo, Claudio Arnaldo Len, et al.
Lupus|May 20, 2022
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndromeFlavio Signorelli, Gustavo Guimarães Moreira Balbi, Nadia E Aikawa, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 4, 2025
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 StudyLeonard V K Kupa, Ana Cristina Medeiros-Ribeiro, Nádia E Aikawa, et al.
Annals of the Rheumatic Diseases|February 9, 2022
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritisAna Cristina Medeiros-Ribeiro, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, et al.
Nature|February 18, 2021
Localization of lattice dynamics in low-angle twisted bilayer grapheneAndreij C Gadelha, Douglas A A Ohlberg, Cassiano Rabelo, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Journal of Physical Activity & Health|March 4, 2023
Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic DiseasesBruno Gualano, Sofia M Sieczkowska, Ítalo Ribeiro Lemes, et al.
Clinics (Sao Paulo, Brazil)|December 18, 2022
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster doseRosa M R Pereira, Marilia A Dagostin, Valeria F Caparbo, et al.
Arthritis Care & Research|November 22, 2021
Impact of Distinct Therapies on Antibody Response to SARS-CoV-2 Vaccine in Systemic Lupus ErythematosusEmily F N Yuki, Eduardo F Borba, Sandra G Pasoto, et al.
Journal of Physical Activity & Health|June 8, 2023
No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After VaccinationFabiana Infante Smaira, Bruna Caruso Mazzolani, Ítalo Ribeiro Lemes, et al.
The Lancet. HIV|March 26, 2022
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort studyLucas C Netto, Karim Y Ibrahim, Camila M Picone, et al.
Revista Brasileira De Reumatologia|June 9, 2016
Guidelines for the management and treatment of periodic fever syndromes: Cryopyrin-associated periodic syndromes (cryopyrinopathies - CAPS)Maria Teresa R A Terreri, Wanderley Marques Bernardo, Claudio Arnaldo Len, et al.
Lupus|May 20, 2022
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndromeFlavio Signorelli, Gustavo Guimarães Moreira Balbi, Nadia E Aikawa, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 4, 2025
Disease Safety, Immunogenicity, and Efficacy of Recombinant Herpes Zoster Vaccine (RZV or Shingrix) in Autoimmune Rheumatic Diseases: Launching a Randomized Phase 4 StudyLeonard V K Kupa, Ana Cristina Medeiros-Ribeiro, Nádia E Aikawa, et al.
Annals of the Rheumatic Diseases|February 9, 2022
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritisAna Cristina Medeiros-Ribeiro, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, et al.
Nature|February 18, 2021
Localization of lattice dynamics in low-angle twisted bilayer grapheneAndreij C Gadelha, Douglas A A Ohlberg, Cassiano Rabelo, et al.
Pageof 13